Bain & Company's Kapur on Healthcare Private Equity

The video discusses the healthcare investment landscape in China, highlighting cautious optimism due to reopening and macro demand. It covers expected deal flow recovery, sector opportunities in biopharma and medical devices, and regulatory and demographic challenges. The video also explores global healthcare trends, focusing on Asia Pacific markets like India and Japan.

What factors contributed to the down year in healthcare investment in China last year?

How is the aging population in China expected to impact healthcare demand?

What are the expectations for deal flow in the healthcare sector this year?

Which sectors within healthcare are expected to see increasing consolidation?

What regulatory changes are anticipated to support domestic innovation in China's healthcare sector?

How does the demographic shift in China present opportunities in the healthcare market?

What trends are being observed in healthcare private equity and M&A beyond China?